Novo Nordisk A/S’s weight-loss drug semaglutide, sold as the once-weekly Wegovy shot, was effective as a daily pill in a…
Browsing: Clinical Updates
Abstract: The use of combination therapy with a biologic agent and immunosuppressant has well-established efficacy and safety and is common practice…
First-degree relatives of people with advanced adenomas have an increased risk for colorectal cancer, yet this risk often is unrecognized…
CHICAGO — Digital gut-directed hypnotherapy resulted in greater improvement in abdominal pain and stool symptoms in patients with irritable bowel…
DUBLIN — A swallowable gastric balloon (Allurion Balloon, formerly known as Elipse) combined with daily subcutaneous injections of the glucagon-like…
The American College of Gastroenterology recently released an updated clinical guideline on the diagnosis and management of celiac disease (Am…
Key takeaways: The FDA has approved AbbVie’s Rinvoq as a once-day pill intended for the treatment of adult patients with…
Scientific evidence, not popular ideas, should drive probiotic and prebiotic recommendations in clinical settings. Globally, evidence is continually emerging on…
In the half-century since the first colonoscopy was performed in 1969, the procedure has become a mainstay for managing colorectal…
Initial treatment with over-the-scope clips (OTSCs) appears superior to standard endoscopic treatment in reducing the risk for further bleeding from…